Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Conflict of interest The authors declare that they have no conflicts of interest
Contrave combines naltrexone and bupropion, two medications that act on brain pathways linked to appetite and cravings
Half-sandwich rhodium(III) transfer hydrogenation catalysts: Reduction of NAD+ and pyruvate, and antiproliferative activity
Gubra has initiated the first-in-human Phase 1/2a trial of GUB-UCN2, a CRHR2 agonist being studied both alone and in combination with incretin-based therapy
Mistake 05 Purchasing Without Third-Party Purity Verification Research chemicals are not subject to pharmaceutical manufacturing standards
US$ 20.79
US$ 27.17
US$ 23.09
US$ 25.47
US$ 24.85
US$ 25.33
US$ 28.51
US$ 26.13
